<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38152586</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-5099</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in molecular neuroscience</Title><ISOAbbreviation>Front Mol Neurosci</ISOAbbreviation></Journal><ArticleTitle>Editorial: Neuropsychiatric and neurodegenerative aspects of acute and long COVID.</ArticleTitle><Pagination><StartPage>1343930</StartPage><MedlinePgn>1343930</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1343930</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnmol.2023.1343930</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almulla</LastName><ForeName>Abbas F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Hakeim</LastName><ForeName>Hussein K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Faculty of Science, University of Kufa, Kufa, Iraq.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Mol Neurosci</MedlineTA><NlmUniqueID>101477914</NlmUniqueID><ISSNLinking>1662-5099</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Editorial on the Research Topic Neuropsychiatric and neurodegenerative aspects of acute and long COVID</RefSource></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuro-immune</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neuropsychiatric disorders</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>28</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38152586</ArticleId><ArticleId IdType="pmc">PMC10751905</ArticleId><ArticleId IdType="doi">10.3389/fnmol.2023.1343930</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Hadrawi D. S., Al-Rubaye H. T., Almulla A. F., Al-Hakeim H. K., Maes M. (2022). Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to long COVID: a precision nomothetic approach. Acta Neuropsychiatr. 35, 76&#x2013;87. 10.1017/neu.2022.21</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2022.21</ArticleId><ArticleId IdType="pubmed">36134517</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H. K., Al-Rubaye H. T., Al-Hadrawi D. S., Almulla A. F., Maes M. (2022). Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol. Psychiatry 28, 564&#x2013;578. 10.1038/s41380-022-01836-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jassas H. K., Al-Hakeim H. K., Maes M. (2022). Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: a nomothetic network approach. J. Affect. Disord. 297, 233&#x2013;245. 10.1016/j.jad.2021.10.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.10.039</ArticleId><ArticleId IdType="pmc">PMC8541833</ArticleId><ArticleId IdType="pubmed">34699853</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Al-Hakeim H. K., Maes M. (2023a). Chronic fatigue and affective symptoms in acute and long COVID are attributable to immune-inflammatory pathways. Psychiatry Clin. Neurosci. 77, 125&#x2013;126. 10.1111/pcn.13514</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13514</ArticleId><ArticleId IdType="pmc">PMC9877923</ArticleId><ArticleId IdType="pubmed">36454120</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Maes M., Bo Z., Hussein K. A.-H., Aristo V. (2023b). Brain-targeted autoimmunity is strongly associated with long COVID and its chronic fatigue syndrome as well as its affective symptoms. medRxiv [preprint]. 10.1101/2023.10.04.23296554</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.10.04.23296554</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A. F., Supasitthumrong T., Tunvirachaisakul C., Algon A. A. A., Al-Hakeim H. K., Maes M. (2022). The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis. BMC Infect. Dis. 22, 615. 10.1186/s12879-022-07582-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07582-1</ArticleId><ArticleId IdType="pmc">PMC9284970</ArticleId><ArticleId IdType="pubmed">35840908</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Liu J., Lin J., Shang H. (2022). COVID-19 and risk of neurodegenerative disorders: a Mendelian randomization study. Transl. Psychiatry 12, 283. 10.1038/s41398-022-02052-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-02052-3</ArticleId><ArticleId IdType="pmc">PMC9281279</ArticleId><ArticleId IdType="pubmed">35835752</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M. (2022). Precision nomothetic medicine in depression research: a new depression model, and new endophenotype classes and pathway phenotypes, and a digital self. J. Pers. Med. 12, 403. 10.3390/jpm12030403</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12030403</ArticleId><ArticleId IdType="pmc">PMC8955533</ArticleId><ArticleId IdType="pubmed">35330403</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Almulla A. F., Bo Z., Hussein K. A.-H., Michael M. (2023). Reactivation of herpesvirus type-6 and IgA/IgM-mediated responses to activin-A underpin Long COVID, including affective symptoms and chronic fatigue syndrome. medRxiv [preprint]. 10.1101/2023.07.23.23293046</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.07.23.23293046</ArticleId><ArticleId IdType="pubmed">38571295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>